 |
 |  |
 |
|
 |
|
 |
|
We aim to play the role of
bridge between excellent research and technology seeds that
universities and research institutions possess and the industrial
needs, and actively involved in industry-academia-government
collaboration and activities of finding, investing in and fostering
tech ventures, especially university-launched venture firms. |
|
 |
|
 |
 Main activities
 |
- Provided support for the formulation of the first venture firm launched from a national university.
- Established technology / seeds funds and performed investment activities.
- Y2002 White Snow No. 2 Investment Limited Partnership established.
- Y2005 Sapporo “Genki” Technology Investment
Limited Partnership established. >List
of Investment Funds
- Formed business alliance with Hokkaido Technology Licensing Office (TLO) Co., Ltd. in respect to the establishment of university-launched venture firms and support for patent strategies.
- Established close tie with biotech clusters outside Hokkaido.
<Business Partners>
Bio-Sight
Capital Co., Ltd. (Kansai region, Japan)
B-Bridge
International, Inc. (California, USA)
- Established a think tank called HVC Strategic Research
Institute, Inc., which conducts business consulting for
tech venture firms and research on industry-academia alliance,
>HVC
Strategic Research Institute, Inc.
- Activities by managing director of HVC
Preliminary Review Committee member of the NEDO’s “R&D Project for
Creation and Commercialization of University-Launched Businesses”, a judge
of the Japan Industrial Journal’s “Japan Biotech Venture Award”,
and lecturer for the course to help create entrepreneurs at CAST, Hokkaido University
|
HVC Incubation Model
|
| Before actual start-up of a business, we evaluate its research / technology, simulate its launching process of that particular business, develop a technology plan, decide commercialization strategies, and develop a business plan to alleviate commercialization risks and increase the rate of successful launch. |
Comparison of the drug development sector in bioindustry between Japan and the United States
|
| In order to commercialize the excellent research results of universities and research institutions, it is necessary to have a company that can play the role of bridge with industry. |
|
|
top